Basic & Clinical Pharmacology & Toxicology

Top Research Topics at Basic & Clinical Pharmacology & Toxicology?

The discussions in Basic & Clinical Pharmacology & Toxicology mainly cover the fields of Pharmacology, Internal medicine, Endocrinology, Biochemistry and Anesthesia. The work on Pharmacology tackled in Basic & Clinical Pharmacology & Toxicology brings together disciplines like Oxidative stress, Toxicity and In vivo. While work presented in the journal provided substantial information on Internal medicine, it also covered topics in Gastroenterology, Diabetes mellitus and Cardiology.

Insulin is a major topic of Endocrinology research presented in it. Biochemistry, which encompasses Antioxidant and Glutathione, is the main subject of Basic & Clinical Pharmacology & Toxicology.

• Pharmacology (31.00%)
• Internal medicine (30.75%)
• Endocrinology (21.05%)

What are the most cited papers published in the journal?

• Antidepressants in the Treatment of Neuropathic Pain (453 citations)
• Indications for Propensity Scores and Review of their Use in Pharmacoepidemiology (428 citations)
• The Nordic countries as a cohort for pharmacoepidemiological research. (399 citations)

Research areas of the most cited articles at Basic & Clinical Pharmacology & Toxicology:

The most cited papers mostly deal with topics like Pharmacology, Internal medicine, Endocrinology, Biochemistry and Antioxidant. The featured Pharmacology studies in the published articles mainly concentrate on Apoptosis but also cover areas of interest in Cancer research. The journal articles feature Internal medicine research that overlaps with concepts in Gastroenterology.

What topics the last edition of the journal is best known for?

• Internal medicine
• Enzyme
• Gene

The previous edition focused in particular on these issues:

Basic & Clinical Pharmacology & Toxicology primarily tackles Internal medicine, 2019-20 coronavirus outbreak, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Pharmacology and Endocrinology. Basic & Clinical Pharmacology & Toxicology facilitates discussions on Internal medicine that incorporate concepts from other fields like Gastroenterology and Cardiology. The presented 2019-20 coronavirus outbreak research focuses mostly on Control (management) and, on occasion, topics in Medical education.

The studies on Pharmacology discussed can also contribute to research in the domains of In vitro, Toxicity and In vivo. Studies on Endocrinology discussed in Basic & Clinical Pharmacology & Toxicology link to the field of Inflammation. Pharmacodynamics is a primary topic of Pharmacokinetics research in Basic & Clinical Pharmacology & Toxicology.

The most cited articles from the last journal are:

• BCPT policy for experimental and clinical studies (37 citations)
• Camostat mesylate against SARS-CoV-2 and COVID-19-Rationale, dosing and safety. (32 citations)
• The tyrosine kinase inhibitor nilotinib inhibits SARS-CoV-2 In Vitro. (10 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Basic & Clinical Pharmacology & Toxicology (based on the number of publications) are:

• Anton Pottegård (33 papers) published 2 papers at the last edition, 2 less than at the previous edition,
• Kim Brøsen (29 papers) published 1 paper at the last edition the same number as at the previous edition,
• Jesper Hallas (29 papers) published 3 papers at the last edition, 1 less than at the previous edition,
• Per Damkier (26 papers) published 4 papers at the last edition, 2 more than at the previous edition,
• Pertti J. Neuvonen (25 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Basic & Clinical Pharmacology & Toxicology (based on the number of publications) are:

• University of Copenhagen (149 papers) published 12 papers at the last edition the same number as at the previous edition,
• University of Southern Denmark (119 papers) published 9 papers at the last edition, 4 less than at the previous edition,
• Odense University Hospital (76 papers) published 9 papers at the last edition, 2 more than at the previous edition,
• Aarhus University (73 papers) published 7 papers at the last edition, 5 less than at the previous edition,
• University of São Paulo (60 papers) published 2 papers at the last edition the same number as at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 28.72% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 25.18% were posted by at least one author from the top 10 institutions publishing in the journal. Another 8.63% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 7.19% of all publications and 58.99% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.